EBOS reports FY26 revenue up to NZ$13.5B

• EBOS reported a 9.9% increase in full-year revenue to NZ$13.5 billion alongside an underlying EBITDA rise of 5% to NZ$614 million.
• Following the full-year results release, the EBOS share price traded up 8.58% at $19.66.
• The company stated that the financial outcome reflects completed infrastructure investments and positions the business for lower capital intensity and future growth.

EBOS Group (ASX:EBO) reported its full year results to June 30, delivering total revenue of NZ$13.5 billion and underlying EBITDA of NZ$614 million.

The result compares against the previous corresponding period where the company managed extensive facility upgrades while navigating fluctuating supply chain expenses.

"We delivered solid EBITDA growth, completed the largest infrastructure investment programme in our history and continued to strengthen the quality of our portfolio through disciplined capital allocation and targeted acquisitions," said EBOS Group CEO Adam Hall.

Underlying net profit after tax declined 3.1% to NZ$250 million, while statutory net profit after tax rose 4.7% to NZ$225 million.

In FY26, EBOS deployed around $400 million in capital across capital expenditure, M&A and shareholder returns.

The company stated that entering fiscal 2027, it maintains a stronger portfolio, lower capital intensity, and capacity to pursue future growth opportunities.

Following the announcement, the EBOS Group share price was up at $19.66.

The group completed its four-year, NZ$360 million distribution centre renewal programme during the period, bringing all major logistics facilities to operational status.

The company maintained a final dividend of 61.5 NZ cents.

Management previously focused operations on scaling healthcare and animal care divisions while maintaining a target leverage range between 1.7x and 2.3x.